Enticare Funding: How Much Did They Raise & Key Investors

How Much Did Enticare Raise?
Funding & Key Investors

Enticare, a prominent healthcare provider specializing in otolaryngology and comprehensive head and neck treatments, has successfully secured a major strategic investment. This latest infusion of capital brings the firm's total funding to $1.8M, with the most recent financing round contributing $935K to its balance sheet. This significant debt-based injection underscores the company's robust operational footprint across the Greater Phoenix metropolitan area and its commitment to scaling specialized medical services.

The financial trajectory of Enticare reflects a consistent pattern of growth, beginning with initial debt financing in 2020, followed by subsequent capital injections in 2021 and the most recent major strategic investment in late 2024. This progression highlights the firm's ability to leverage debt instruments to expand its clinical capacity and service offerings in a competitive healthcare landscape.

What is Enticare?

Enticare

Hospitals & Physicians Clinics

Physicians Clinics

Medical Practice Management

Enticare operates as a multi-disciplinary healthcare organization with a primary focus on Ear, Nose, and Throat (ENT) services, audiology, sleep medicine, and allergy treatments. By maintaining seven strategic locations throughout Greater Phoenix, the company provides a comprehensive suite of surgical and non-surgical interventions. The organization distinguishes itself through a collaborative care model that integrates audiologists, nurse practitioners, and respiratory therapists to deliver personalized patient outcomes. Their market position is defined by high-acuity care delivery and a focus on chronic condition management, which remains a critical component of the regional healthcare infrastructure.

How much funding has Enticare raised?

Enticare has raised a total of $1.8M across 3 funding rounds:

2020

Debt

$350K

2021

Debt

$558K

2024

Debt

$935K

Debt (2020): $350K with participation from PPP

Debt (2021): $558K led by PPP

Debt (2024): $935K supported by Wells Fargo

Key Investors in Enticare

Wells Fargo

A multinational financial services firm providing comprehensive banking, investment, and commercial lending solutions to large-scale enterprises.

PPP

Public-Private Partnership

What's next for Enticare?

With the successful acquisition of this latest capital, Enticare is well-positioned to accelerate its operational expansion and enhance its technological capabilities in diagnostic testing. The strategic deployment of these funds will likely focus on increasing patient throughput, upgrading clinical facilities, and potentially broadening its service reach within the Arizona market. As the healthcare sector continues to prioritize integrated, patient-centric care models, Enticare's focus on specialized ENT and sleep medicine provides a stable foundation for long-term growth and market consolidation. The firm's reliance on debt-based financing suggests a disciplined approach to capital management, prioritizing sustainable infrastructure development over rapid, speculative expansion.

See full Enticare company page

See More Financial Insights